REFERENCE
PHARMAC.350 women each year to benefit from Herceptin funding decision. Media Release: 3 May 2007. Available from: URL: http://www.pharmac.govt.nz
Rights and permissions
About this article
Cite this article
New Zealand's drug subsidy agency, Pharmac, is to fund trastuzumab for HER2-positive early breast cancer.. Pharmacoecon. Outcomes News 530, 11 (2007). https://doi.org/10.2165/00151234-200705300-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705300-00033